Skip to content

Kevin Batty

  • BPharm, MSc, PhD
  • Professor & Head of School (Pharmacy and Biomedical Sciences)
  • Curtin University
  • 22h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 1587CitationsNumber of citations received by Kevin's publications. Updated daily.

About

Professor Kevin Batty was appointed Head of School in May 2014. He has a 30-year career in pharmacy, including 10 years as a hospital pharmacist and 15 years as a university academic. His research interests are in the fields of pharmacokinetics and antimalarial pharmacology.

Research interests

Recent publications

  • Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women

    • Benjamin J
    • Moore B
    • Salman S
    • et al.
    N/AReaders
    20Citations
  • Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria

    • Moore B
    • Benjamin J
    • Salman S
    • et al.
    N/AReaders
    15Citations

Professional experience

Professor & Head of School (Pharmacy and Biomedical Sciences)

Curtin University

January 2018 - Present

Professor & Head of School (Pharmacy)

Curtin University of Technology

May 2014 - December 2017(4 years)

Director, Higher Education

West Coast Institute of Training

October 2012 - May 2014(2 years)

A/Professor

Curtin University of Technology

January 2006 - October 2012(7 years)

Education

Grad Cert Business (Management)

The University of Notre Dame, Australia

February 2014 - November 2014(9 months)

PhD

University of Western Australia

April 1994 - December 1998(5 years)

MSc

Victoria University of Manchester

October 1988 - October 1989(a year)

BPharm

Curtin University of Technology

February 1979 - November 1982(4 years)